Screener
Edwards Lifesciences EW EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from Edwards Lifesciences’s reported figures.
Based on trailing twelve months.
The source filing: Edwards Lifesciences’s 10-Q, filed May 6, 2026. Open the filing →
- Filed
- May 6, 2026, 4:12 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001099800-26-000026
FAQ
- What is Edwards Lifesciences's EBITDA margin?
- Edwards Lifesciences (EW) reported EBITDA margin of 23.9% in Q1 2026.
- How has Edwards Lifesciences's EBITDA margin changed year-over-year?
- Edwards Lifesciences's EBITDA margin decreased by 16.3% year-over-year, from 28.6% to 23.9%.
- What is the long-term trend for Edwards Lifesciences's EBITDA margin?
- Over 5 years (2020 to 2025), Edwards Lifesciences's EBITDA margin has grown at a 0.4% compound annual growth rate (CAGR), from 22.9% to 23.4%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about Edwards Lifesciences's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude